Surgery Partners, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US86881A1007
USD
17.38
0.62 (3.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Surgery Partners, Inc. stock-summary
stock-summary
Surgery Partners, Inc.
Hospital
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company's Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company's surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company's Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company's physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company's Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Company Coordinates stock-summary
Company Details
310 Seven Springs Way Ste 500 , BRENTWOOD TN : 37027-5679
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 69 Schemes (48.89%)

Foreign Institutions

Held by 117 Foreign Institutions (6.91%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Wayne DeVeydt
Executive Chairman of the Board
Mr. J. Eric Evans
Chief Executive Officer, Director
Mr. Clifford Adlerz
Director
Mr. John Deane
Independent Director
Dr. Teresa DeLuca
Independent Director
Mr. Andrew Kaplan
Independent Director
Mr. T. Devin O'Reilly
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
826 Million
(Quarterly Results - Jun 2025)
Net Profit:
45 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 2,831 Million (Small Cap)

stock-summary
P/E

39.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.43

stock-summary
Return on Equity

5.15%

stock-summary
Price to Book

1.62